Dare Bioscience Inc (DARE)
0.3112
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.30
-0.01
(-3.60%)
After-Hours: 05:20
Dare Bioscience Total Liabilities (Quarterly): 26.33M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.33M |
| September 30, 2023 | 27.34M |
| June 30, 2023 | 25.93M |
| March 31, 2023 | 25.40M |
| December 31, 2022 | 32.71M |
| September 30, 2022 | 24.03M |
| June 30, 2022 | 18.36M |
| March 31, 2022 | 18.31M |
| December 31, 2021 | 17.05M |
| September 30, 2021 | 16.92M |
| June 30, 2021 | 7.078M |
| March 31, 2021 | 7.260M |
| December 31, 2020 | 8.702M |
| September 30, 2020 | 9.048M |
| June 30, 2020 | 8.259M |
| March 31, 2020 | 7.000M |
| December 31, 2019 | 7.002M |
| September 30, 2019 | 2.072M |
| June 30, 2019 | 2.178M |
| March 31, 2019 | 1.240M |
| December 31, 2018 | 1.101M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.212M |
| June 30, 2018 | 1.266M |
| March 31, 2018 | 0.8105M |
| December 31, 2017 | 0.967M |
| September 30, 2017 | 0.8395M |
| June 30, 2017 | 4.092M |
| March 31, 2017 | 8.212M |
| December 31, 2016 | 0.7552M |
| September 30, 2016 | 23.51M |
| June 30, 2016 | 24.05M |
| March 31, 2016 | 27.04M |
| December 31, 2015 | 29.48M |
| September 30, 2015 | 21.47M |
| June 30, 2015 | 19.90M |
| March 31, 2015 | 18.97M |
| December 31, 2014 | 8.068M |
| September 30, 2014 | 7.554M |
| June 30, 2014 | 7.931M |
| March 31, 2014 | 108.89M |
| December 31, 2013 | 101.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.072M
Minimum
Sep 2019
32.71M
Maximum
Dec 2022
15.32M
Average
16.92M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Altimmune Inc | 16.54M |
| Verastem Inc | 92.34M |
| Oragenics Inc | 1.798M |
| Actinium Pharmaceuticals Inc | 44.50M |
| Orgenesis Inc | 35.54M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.28M |
| Shareholders Equity (Quarterly) | -5.048M |
| Current Ratio | 0.8566 |